Artificial Skin (Integra” Dermal Regeneration Template) for Closure of Lower Extremity Wounds

Vascular and Endovascular Surgery

Volumn 34, Issue 6, 2000, Pages 557-567

  Prystowsky, Janet H ^a   Nowygrod, Roman ^a   Marboe, Charles C ^a   Benvenisty, Alan I ^a   Ascherman, Jeffrey A ^a   Todd, George J ^b  

^a The New York Presbyterian Hospital ^*

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL SKIN; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; LEG ULCER; MALE; SCHOOL CHILD; SKIN AUTOGRAFT; SKIN CANCER; SKIN DISEASE; SPLIT THICKNESS SKIN GRAFT; TENDON; TISSUE REGENERATION; WOUND CLOSURE; WOUND DRESSING; WOUND HEALING;

EID: 0033678942     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/153857440003400610     Document Type: Article

References (6)

1. Medical Economics of Integra” Artificial Skin. Integra LifeSciences Corp, PO Box 688, 105 Morgan Lane, Plainsboro, NJ 08536.
2. Heimbach D, Luterman A, Burke J., et al: Artificial dermis for major burns: A multi-center randomized clinical trial. Ann Surg 208: 313-320, 1988.
3. Singer AJ, Clark RAF: Cutaneous wound healing. N Engl J Med 341: 738-746, 1999.
4. Eaglstein WH, Iriondo M, Laszlo K: A composite skin substitute (graftskin) for surgical wounds: A clinical experience. Dermatol Surg 21: 839-843, 1995.
5. Falanga V, Margolis D, Alvarez O, et al: Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol 134: 293-300, 1998.
6. Smiell JM: Clinical safety of becaplermin (rhPDGF-BB) gel. Becaplermin Studies Group. Am J Surg 176: 68S-73S, 1998.